Cargando…

Immunization With Fc-Based Recombinant Epstein–Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model

Epstein–Barr virus (EBV) was the first human virus proved to be closely associated with tumor development, such as lymphoma, nasopharyngeal carcinoma, and EBV-associated gastric carcinoma. Despite many efforts to develop prophylactic vaccines against EBV infection and diseases, no candidates have su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Bingchun, Zhang, Xiao, Krummenacher, Claude, Song, Shuo, Gao, Ling, Zhang, Haojiong, Xu, Miao, Feng, Lin, Feng, Qisheng, Zeng, Musheng, Xu, Yuting, Zeng, Yixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938345/ https://www.ncbi.nlm.nih.gov/pubmed/29765376 http://dx.doi.org/10.3389/fimmu.2018.00932

Ejemplares similares

Urgency and necessity of Epstein-Barr virus prophylactic vaccines
por: Zhong, Ling, et al.
Publicado: (2022)

A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
por: Zhong, Ling, et al.
Publicado: (2022)

Induction of chemokine (C‐C motif) ligand 5 by Epstein–Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma
por: Ma, Wenlong, et al.
Publicado: (2018)

Epitope mapping of gp350/220 conserved domain of epstein barr virus to develop nasopharyngeal carcinoma (npc) vaccine
por: Sitompul, Loly Sabrina, et al.
Publicado: (2012)

Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture
por: Tanner, Jerome E., et al.
Publicado: (2018)

Evaluation of Measles Vaccine Virus as a Vector to Deliver Respiratory Syncytial Virus Fusion Protein or Epstein-Barr Virus Glycoprotein gp350
por: Mok, Hoyin, et al.
Publicado: (2012)

CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease
por: Slabik, Constanze, et al.
Publicado: (2020)

Development of an Improved Epstein-Barr Virus (EBV) Neutralizing Antibody Assay to Facilitate Development of a Prophylactic gp350-Subunit EBV Vaccine
por: Liu, Hui, et al.
Publicado: (2020)

Differentiated tumor immune microenvironment of Epstein–Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy
por: Ma, Jing, et al.
Publicado: (2017)

The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells
por: Gram, Anna M., et al.
Publicado: (2016)

Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies
por: Xu, Miao, et al.
Publicado: (2019)

Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses
por: Kong, Xiang-Wei, et al.
Publicado: (2022)

Epstein–Barr Virus, the Immune System, and Associated Diseases
por: Chen, Mei-Ru
Publicado: (2011)

Epstein–Barr Virus and Innate Immunity: Friends or Foes?
por: Jangra, Sonia, et al.
Publicado: (2019)

Comparison of Humoral Immune Responses to Epstein-Barr Virus and Kaposi’s Sarcoma–Associated Herpesvirus Using a Viral Proteome Microarray
por: Zheng, Dasheng, et al.
Publicado: (2011)

Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation
por: Zhang, Hao-Jiong, et al.
Publicado: (2018)

Epstein–Barr Virus-Specific Immune Control by Innate Lymphocytes
por: Münz, Christian
Publicado: (2017)

Schizophrenia is Associated With an Aberrant Immune Response to Epstein–Barr Virus
por: Dickerson, Faith, et al.
Publicado: (2019)

Immune Escape by Non-coding RNAs of the Epstein Barr Virus
por: Münz, Christian
Publicado: (2021)

FcRn Overexpression Expands Diversity of the Humoral Immune Response in bFcRn Transgenic Mice
por: Szikora, Bence, et al.
Publicado: (2020)

The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
por: Sun, Cong, et al.
Publicado: (2021)

In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39
Publicado: (1993)

Identifying the key genes of Epstein–Barr virus‐regulated tumour immune microenvironment of gastric carcinomas
por: Zhou, Heng, et al.
Publicado: (2022)

Epstein-Barr virus: From kisses to cancer, an ingenious immune evader
por: Trivedi, Pankaj, et al.
Publicado: (2018)

Immune Control and Vaccination against the Epstein–Barr Virus in Humanized Mice
por: Münz, Christian
Publicado: (2019)

CryoEM structure of the tegumented capsid of Epstein-Barr virus
por: Li, Zhihai, et al.
Publicado: (2020)

Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients
por: Shen, Yong, et al.
Publicado: (2015)

Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer
por: Liu, Zhenjiang, et al.
Publicado: (2018)

Epstein-Barr virus-encoded microRNAs as regulators in host immune responses
por: Wang, Man, et al.
Publicado: (2018)

An update: Epstein-Barr virus and immune evasion via microRNA regulation
por: Zuo, Lielian, et al.
Publicado: (2017)

Epstein barr virus encodes miRNAs to assist host immune escape
por: Li, Weiming, et al.
Publicado: (2020)

Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection
por: Münz, Christian
Publicado: (2021)

Immunoinformatic Analysis Reveals Antigenic Heterogeneity of Epstein-Barr Virus Is Immune-Driven
por: Cirac, Ana, et al.
Publicado: (2021)

Altered Immune Response to the Epstein–Barr Virus as a Prerequisite for Multiple Sclerosis
por: Läderach, Fabienne, et al.
Publicado: (2022)

Secondary Immune Thrombocytopenic Purpura Due to Primary Epstein- Barr Virus Infection
por: Yusuf, Heba, et al.
Publicado: (2022)

Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement
por: Lofano, Giuseppe, et al.
Publicado: (2018)

Immune responses to Epstein–Barr virus: molecular interactions in the virus evasion of CD8(+) T cell immunity
por: Rowe, Martin, et al.
Publicado: (2010)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

ASTE1 frameshift mutation triggers the immune response in Epstein-Barr virus-associated gastric cancer
por: Huang, Binhao, et al.
Publicado: (2022)

A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits
por: Escalante, Gabriela M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pv2ph49c5rhl70mt1h2ufssoti